Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Changkang Granule in IBS-D
NCT04492787Phase 2Completed
- Sponsor
- Tasly Pharmaceutical Group Co., Ltd.
- Start
- Jul 2020
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of changkang granules in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by Tasly Pharmaceutical Group Co., Ltd.. Started Jul 2020; status: completed.
02
Drugs
changkang granules
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on NCT04492787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04492787.